Core Viewpoint - The stock of Debon Logistics Co., Ltd. has experienced a decline in recent trading sessions, with a notable drop in both stock price and net inflow of funds, indicating potential challenges in the market [1][2]. Group 1: Stock Performance - As of November 18, Debon shares fell by 2.01%, trading at 14.66 yuan per share, with a total market capitalization of 14.95 billion yuan [1]. - Year-to-date, Debon’s stock price has increased by 3.34%, but it has seen declines of 2.14% over the last five trading days, 4.12% over the last 20 days, and 13.31% over the last 60 days [1]. - The company has appeared on the trading leaderboard four times this year, with the most recent instance on June 6, where it recorded a net buy of -161 million yuan [1]. Group 2: Financial Performance - For the period from January to September 2025, Debon reported a revenue of 30.27 billion yuan, reflecting a year-on-year growth of 6.97%, while the net profit attributable to shareholders was -277 million yuan, a decrease of 153.54% compared to the previous year [2]. - Since its A-share listing, Debon has distributed a total of 784 million yuan in dividends, with 227 million yuan distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Debon was 36,900, a decrease of 4.25% from the previous period, with an average of 27,623 shares held per shareholder, an increase of 4.43% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 6.02 million shares, a decrease of 6.71 million shares from the previous period [3].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - In Q3 2025, the company reported a revenue of 9.72 billion yuan, a year-on-year decrease of 1.4%, and a net profit attributable to shareholders of -330 million yuan, a year-on-year decline of 278.6% [2][4]. - The gross margin for Q3 2025 decreased by 5.6 percentage points to 1.8%, primarily due to weak macro demand and adjustments in product structure, leading to a decline in revenue [2][4]. - The company is positioned as a leading direct-operated express delivery service provider, and despite short-term operational disruptions, the long-term value of the network is expected to remain intact, with hopes for improved operational performance in the future [2][4]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 30.27 billion yuan, representing a year-on-year growth of 7.0%, while the net profit attributable to shareholders was -280 million yuan, a year-on-year decline of 153.5% [4]. - In Q3 2025, the revenue breakdown showed express delivery and other business revenues decreased by 18.9% and increased by 9.4%, respectively, indicating a shift in product focus [6]. Cost and Margin Analysis - The gross margin for Q3 2025 was significantly impacted, dropping to 7.4% due to increased labor costs and other operational expenses, with labor costs rising by 9.6% year-on-year [6]. - Management expenses increased by 22.3% to 320 million yuan, reflecting higher investments in backend support resources following strategic adjustments [6]. Future Outlook - The company is expected to recover its profitability with projected net profits of -70 million yuan, 510 million yuan, and 760 million yuan for 2025, 2026, and 2027, respectively [6]. - The anticipated price-to-earnings ratios for 2026 and 2027 are 30.0x and 20.1x, respectively, indicating a potential for growth as operational adjustments take effect [6].

Core Viewpoint - The delivery services of several express companies in the Chengdu New District have been suspended, causing significant inconvenience for residents during the peak shopping period of "Double 11" [2][4]. Group 1: Delivery Issues - Residents in the New Chuan District reported that multiple express companies, including Zhongtong, Yuantong, Shentong, and Yunda, indicated that their locations were "undeliverable" due to reasons such as "address cannot be delivered" and "the order's delivery area cannot be dispatched" [2][3]. - The situation is affecting several residential complexes, with reports confirming that 2-5 express companies are showing "undeliverable" status for each complex [3]. Group 2: Reasons for Delivery Suspension - The primary reasons for the suspension of delivery services include the lack of delivery points in the area and a high volume of complaints from residents regarding lost or damaged packages [4][6]. - Many residential complexes lack dedicated express delivery stations, leading to a significant increase in delivery volume, with some complexes experiencing over 1,000 packages daily during "Double 11" [6]. - Complaints from residents about delivery issues have increased, prompting express companies to halt services due to operational inefficiencies and rising costs [6]. Group 3: Solutions Being Implemented - Community staff have reported that measures are being taken to address the delivery issues, including converting parts of property management offices into temporary pick-up points for packages [7]. - New temporary storage solutions, such as delivery cabinets and designated areas for package storage, are being established to facilitate the collection of packages by residents [7]. - Plans are in place to develop a neighborhood center that will integrate various services, including express delivery, to improve logistics in the area [7].

Core Viewpoint - The incident highlights significant issues with the compensation process of Debon Express, particularly regarding the handling of fragile items and the inadequacy of their insurance claims process [4][6][10]. Summary by Sections Incident Description - A customer, Ms. Li, sent a set of fragile porcelain tableware valued over 3000 yuan via Debon Express, specifically requesting enhanced protection during shipping [4][5]. - Upon delivery, the items were found severely damaged, with the outer packaging lacking adequate protection [4][5]. Compensation Process - Ms. Li initiated a claim but faced a convoluted process, with initial compensation offers of 80 yuan and later 200 yuan, both significantly below the insured value [6][10]. - The customer was required to pay the shipping fee before the claim could be processed, which raised concerns about the transparency and fairness of the compensation process [6][10]. Legal and Regulatory Context - Ms. Li cited relevant regulations, asserting her right to full compensation based on the market value of the damaged goods, which was higher than the insured amount [7][12]. - The legal expert noted that Debon Express's compensation rules may lack sufficient legal backing and could be deemed unfair under consumer protection laws [12][13]. Consumer Sentiment and Industry Trends - Similar complaints against Debon Express have surfaced on social media, indicating a pattern of inadequate compensation and poor customer service [8][9]. - The company's compensation practices have led to widespread dissatisfaction among consumers, with many feeling that the promised insurance coverage is ineffective [8][9]. Company Response - Debon Express acknowledged the issue and has since agreed to compensate Ms. Li based on the actual loss incurred, following further assessment of the situation [10][11]. - The company emphasized the importance of providing clear evidence of item value during the claims process to facilitate smoother resolutions in the future [11].

1. Report Industry Investment Rating - The industry rating is "Bullish" [1] 2. Core Views of the Report - The cosmetics industry continues to show differentiation, with brand demand being weak in the off - season, agents seeking change in difficult situations, and producers seizing supply - chain reconstruction opportunities. The medical aesthetics industry has new entrants with better - than - expected shipments, and new product catalysts are worth attention [3][4] 3. Summaries According to Relevant Catalogs 3.1 Cosmetics: Continued Differentiation 3.1.1 Brand Merchants - In 1 - 3Q25, beauty brand merchants' revenue was 28.4 billion yuan, a year - on - year decrease of 0.6%; personal care brand merchants' revenue was 5.7 billion yuan, a year - on - year increase of 12.4%. In 3Q25, beauty and personal care brand merchants' revenues were 8.05 billion and 1.805 billion yuan, a year - on - year decrease of 1.3% and an increase of 7.6% respectively. Beauty revenue weakened quarter - on - quarter, while personal care remained flat [18] - Beauty: Affected by the earlier Double Eleven promotion, consumer enthusiasm declined in September, and brands reduced live - streaming activities. In terms of single - quarter revenue growth, Shuiyang Co., Ltd. and Shanghai Jahwa increased by over 20%, Marubi Co., Ltd. had double - digit growth, Proya had low - double - digit decline, and Betaine and Freda had high - single - digit decline [18] - Personal care: Runben Co., Ltd.'s Q3 revenue increased by 17% year - on - year, with a slight increase in growth rate quarter - on - quarter. Baiya Co., Ltd.'s 3Q25 revenue improved, and Dengkang Oral Care had steady growth [18] - In 1 - 3Q25, beauty brand merchants' net profit after non - recurring items was 2.33 billion yuan, a year - on - year decrease of 15%; personal care brand merchants' was 604 million yuan, a year - on - year decrease of 3.4%. Some companies showed initial cost - control effects [24] 3.1.2 Agents - Agents are seeking change in difficult situations by exploring three paths: incubating self - owned brands (represented by Ruoyuchen), using AI to reduce costs and increase efficiency (represented by Yiwow), and expanding high - growth categories (such as Qingmu Technology expanding into trendy toy agency operations) [30] - Ruoyuchen's self - owned brands Feicui and Zhanjia continued to gain momentum. In Q3, self - owned brand revenue was 451 million yuan, a year - on - year increase of 344.5%, accounting for 55.1%. Zhanjia's Q3 revenue was 227 million yuan, a year - on - year increase of 119%, and 1 - 3Q revenue was 680 million yuan. Feicui's Q3 revenue was 203 million yuan, a quarter - on - quarter increase of over 98.8%, and 1 - 3Q revenue was 362 million yuan [30] 3.1.3 Producers - Demand continued to recover, and the revenue of the producer sector increased by 9%, 17%, and 30% year - on - year from Q1 to Q3, with the growth rate increasing quarter by quarter [33] - QingSong Co., Ltd. focused on optimizing customers and product structure, and its profit turned positive for four consecutive quarters from 2Q24 to 1Q25. Jieya Co., Ltd. had increasing orders from overseas big customers, and its Q3 performance growth accelerated. Jiaheng Home Co., Ltd. increased revenue but not profit, mainly due to the short - term impact of the Huzhou base's capacity ramp - up [33] 3.2 Medical Aesthetics: New Entrants with Better - than - Expected Shipments 3.2.1 Upstream Consumables - The growth rate of demand expansion slowed down, and supply - side competition intensified. In terms of the cumulative number of Class III medical device approvals, hyaluronic acid > regenerative (Sculptra/Poly - L - Lactic Acid) > botulinum toxin > recombinant collagen. Old products of hyaluronic acid and regenerative types faced growth pressure, and the growth rate of recombinant collagen Class III medical device products slowed down significantly quarter - on - quarter [38] - Hyaluronic acid: Aimeike's revenue growth rate from 24Q1 to 25Q3 was + 28.2%/+2.3%/+1.1%/ - 7%/ - 18%/ - 25%/ - 21% year - on - year, showing a quarterly decline since 24Q2 [38] - Collagen: Jinbo Biotech's revenue growth rate from 24Q1 to 25Q1 was + 76%/+100%/+92%/+73%/+63% year - on - year, and in 2Q25/3Q25, it was + 30%/+13% year - on - year. On October 23, the "Recombinant Type I α1 Subtype Collagen Freeze - Dried Fiber" Class III medical device certificate of Giant Biogene was approved by NMPA [38] - Leapmed Medical's medical aesthetics shipments were better than expected, with Q3 medical service and health management business revenue of 320 million yuan, a year - on - year increase of 28%, and the revenue of Sculptra and Hydrodermabrasion reaching 86.1367 million yuan [36] 3.2.2 Downstream - The new model of Xinoxygen Medical Clinics showed high - growth potential. The Q3 revenue guidance was 150 - 170 million yuan, a year - on - year increase of 231% - 275%, and a quarter - on - quarter increase of 4% - 18%. It plans to implement the "100 - City, 1000 - Store" plan in the long term [40] - Stores are expanding from first - tier cities to new first - tier and second - tier cities. As of November 6, it covered 42 stores in 10 cities. The promotion of self - owned brands was remarkable, and it cooperated with Xihong Miracle Sculptra 3.0, priced at 2999 yuan, which was officially launched on September 25 [43] 3.3 Investment Recommendations - Brands with upward potential and both growth and certainty: Recommend Maogeping (Oriental aesthetics, dual - wheel drive of makeup and skincare, and the second - curve of perfume is worth looking forward to) and Shangmei Co., Ltd. (with one cornerstone brand, five growth brands, and N seed businesses) [8][46] - Companies with new product pipelines and expected performance elasticity: Pay attention to Giant Biogene and Leapmed Medical [8][46] - Companies in strategic adjustment and expected to reach an inflection point: Recommend Shuiyang Co., Ltd. (the effect of high - end transformation is gradually emerging), and pay attention to Shanghai Jahwa, Betaine, and Freda [8][46]

Group 1 - Shanghai Xuangu Supply Chain Management Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The legal representative of the new company is Liang Yi [1] - The business scope includes supply chain management services, international and domestic freight forwarding, handling and transportation, customs declaration, and import and export of goods [1] Group 2 - The company is wholly owned by Ningbo Xuande Debang Supply Chain Management Co., Ltd., which is a subsidiary of Debang Co., Ltd. (603056) [1]

Core Points - Debon Holdings announced that neither the company nor its subsidiaries have any overdue external guarantees [2] Group 1 - The company confirmed the absence of overdue external guarantees, indicating a stable financial position [2]

证券代码：603056 证券简称：德邦股份 公告编号：2025-061 （一）担保的基本情况 2025 年 10 月，根据生产经营需要，德邦物流股份有限公司（以下简称"公 司"、"本公司"或"德邦股份"）接受宁波宣德德邦供应链管理有限公司（以下 简称"宣德供应链"）、成都全程德邦物流有限公司（以下简称"成都德邦"）委 托，作为申请人向中国农业银行股份有限公司上海长三角一体化示范区支行申请 开立分离式非融资性保函，保函金额分别为人民币 10.87 万元、89.19 万元。 德邦物流股份有限公司 关于为控股子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 担 保 | 对 | 被担保人名称 | | | 宁波宣德德邦供应链管理有限公司 | | --- | --- | --- | --- | --- | --- | | | | 本次担保金额 | 10.87 | 万元 | | | 象一 | | 实际为其提供的担保余额 | 440.63 | 万元 | | | | | 是否在前期预计额度内 | 是 ...

Core Viewpoint - The company, Debon Logistics Co., Ltd., has announced its plan to repurchase shares through centralized bidding, with a total budget ranging from RMB 75 million to RMB 150 million, and a maximum repurchase price of RMB 16.00 per share [2] Group 1: Share Repurchase Plan - The company approved a share repurchase plan at its board meeting on April 24, 2025, and at the annual shareholders' meeting on May 16, 2025 [2] - The repurchase will be conducted within 12 months from the date of the shareholders' approval, with the intention to cancel all repurchased shares and reduce the registered capital [2] Group 2: Adjustments to Repurchase Price - Following the implementation of the 2024 annual equity distribution, the maximum repurchase price was adjusted to RMB 15.85 per share, effective from June 11, 2025 [3] Group 3: Repurchase Progress - As of October 31, 2025, the company has repurchased 268,400 shares, representing 0.03% of the total share capital, with a total expenditure of RMB 4,010,369.00 [4] - The highest and lowest prices for the repurchased shares were RMB 15.04 and RMB 14.90 per share, respectively [4][5] - The cumulative repurchase status as of the end of October 2025 remains consistent with the October repurchase details [5] Group 4: Compliance and Future Actions - The company will adhere to relevant regulations and guidelines during the repurchase period and will disclose information regarding the progress of the share repurchase in a timely manner [7]

Core Viewpoint - Debon Holdings announced the repurchase of 268,400 shares through centralized bidding, representing 0.03% of the company's total share capital [2] Summary by Category - **Share Repurchase Details** - The company has cumulatively repurchased 268,400 shares as of October 31, 2025 [2] - The repurchased shares account for 0.03% of the total share capital [2]